Dose Frequency Ranging Pharmacokinetic Study of Tenofovir-Emtricitabine After Directly Observed Dosing in Healthy Volunteers to Establish Adherence Benchmarks (HPTN 066)Craig W. Hendrix, Kristine B. Patterson, Paul Richardson et al.|AIDS Research and Human Retroviruses|2015Cited by 177
Protein Binding of Lopinavir and Ritonavir During 4 Phases of PregnancyKristine B. Patterson, Angela D. M. Kashuba, Julie B. Dumond et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2012Cited by 41
Effect of HIV Infection and Menopause Status on Raltegravir Pharmacokinetics in the Blood and Genital TractMackenzie L. Cottrell, Angela D. M. Kashuba, Kristine B. Patterson et al.|Antiviral Therapy|2014Cited by 7
Tenofovir/Emtricitabine Metabolites and Endogenous Nucleotide Exposures are associated with p16 <sup>INK4a</sup> Expression in Subjects on Combination TherapyJulie B. Dumond, Alan Forrest, Owen Francis et al.|Antiviral Therapy|2015Cited by 5
Protein Binding of Lopinavir and Ritonavir During 4 Phases of Pregnancy: Implications for Treatment GuidelinesHeather A. Prince, Angela D. M. Kashuba, Kristine B. Patterson et al.|UNC Libraries|2020Cited by 3